377 related articles for article (PubMed ID: 12546990)
21. Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases.
Ebert S; Goos M; Rollwagen L; Baake D; Zech WD; Esselmann H; Wiltfang J; Mollenhauer B; Schliebs R; Gerber J; Nau R
J Neurosci Res; 2010 Apr; 88(5):1124-36. PubMed ID: 19859962
[TBL] [Abstract][Full Text] [Related]
22. The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders I: Parkinson's disease.
Campos HC; da Rocha MD; Viegas FP; Nicastro PC; Fossaluzza PC; Fraga CA; Barreiro EJ; Viegas C
CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):239-50. PubMed ID: 20874702
[TBL] [Abstract][Full Text] [Related]
23. Neurodegenerative disorders and their treatment.
Karran E; Palmer AM
Drug News Perspect; 2007; 20(6):407-12. PubMed ID: 17925895
[TBL] [Abstract][Full Text] [Related]
24. Biomarkers for Managing Neurodegenerative Diseases.
Cheslow L; Snook AE; Waldman SA
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672416
[TBL] [Abstract][Full Text] [Related]
25. [Understanding clinical neuropsychology: a basic approach (2)degenerative disease].
Kobayakawa M
No Shinkei Geka; 2010 Jul; 38(7):675-81. PubMed ID: 20628196
[No Abstract] [Full Text] [Related]
26. Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?
Bonaventura G; Munafò A; Bellanca CM; La Cognata V; Iemmolo R; Attaguile GA; Di Mauro R; Di Benedetto G; Cantarella G; Barcellona ML; Cavallaro S; Bernardini R
Cells; 2021 Aug; 10(8):. PubMed ID: 34440761
[TBL] [Abstract][Full Text] [Related]
27. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
Mattson MP
Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
[TBL] [Abstract][Full Text] [Related]
28. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
Gaggelli E; Kozlowski H; Valensin D; Valensin G
Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
[No Abstract] [Full Text] [Related]
29. [COX plays a pivotal role in the progressive neuronal loss in neurodegenerative diseases].
Gao JP; Sun S; Li WW; Zhao H; Cai DF
Sheng Li Ke Xue Jin Zhan; 2008 Jul; 39(3):214-20. PubMed ID: 18819488
[TBL] [Abstract][Full Text] [Related]
30. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
[TBL] [Abstract][Full Text] [Related]
31. Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics.
Eisen A; Calne D
Can J Neurol Sci; 1992 Feb; 19(1 Suppl):117-23. PubMed ID: 1571856
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
[TBL] [Abstract][Full Text] [Related]
33. P-gp transporter and its role in neurodegenerative diseases.
Rapposelli S; Digiacomo M; Balsamo A
Curr Top Med Chem; 2009; 9(2):209-17. PubMed ID: 19200006
[TBL] [Abstract][Full Text] [Related]
34. Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.
Salman MM; Al-Obaidi Z; Kitchen P; Loreto A; Bill RM; Wade-Martins R
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925236
[TBL] [Abstract][Full Text] [Related]
35. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.
Ganai SA; Banday S; Farooq Z; Altaf M
Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674
[TBL] [Abstract][Full Text] [Related]
36. Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases.
Anilkumar AK; Vij P; Lopez S; Leslie SM; Doxtater K; Khan MM; Yallapu MM; Chauhan SC; Maestre GE; Tripathi MK
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396946
[TBL] [Abstract][Full Text] [Related]
37. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
Mulligan VK; Chakrabartty A
Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
[TBL] [Abstract][Full Text] [Related]
38. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
Mariani E; Polidori MC; Cherubini A; Mecocci P
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
[TBL] [Abstract][Full Text] [Related]
40. The dawn of pirna research in various neuronal disorders.
Wakisaka KT; Imai Y
Front Biosci (Landmark Ed); 2019 Jun; 24(8):1440-1451. PubMed ID: 31136989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
